IL-1beta regulates expression of Cx32, occludin, and claudin-2 of rat hepatocytes via distinct signal transduction pathways

Exp Cell Res. 2004 Oct 1;299(2):427-41. doi: 10.1016/j.yexcr.2004.06.011.

Abstract

The functions of gap and tight junctions are perturbed during the acute-phase response to liver injury. To elucidate the mechanism of pro-inflammatory cytokine IL-1beta responsible for regulation of hepatic gap and tight junctions, we analyzed expression and function of gap and tight junctions using a rat liver injury model and primary cultures of rat hepatocyte. In rat liver lobules at 24 h after thioacetamide (TAA) treatment, where some IL-1beta-positive non-parenchymal cells existed, disappearance of connexin32-positive spots at cell borders of the hepatocytes and increases of claudin-2 and occludin immunoreactivities in bile canalicular regions were observed. In primary cultures of rat hepatocytes, IL-1beta caused the disappearance of connexin32, which was reciprocal to the induction and localization of claudin-2 to cell membranes. The downregulated connexin32 expression was inhibited by treatment with a MAP-kinase inhibitor (PD98059), whereas the upregulated claudin-2 expression was blocked by p38 MAP and PI3-kinase inhibitors (SB203580 and LY294002). The changes of connexin32 and claudin-2 may be controlled at the transcriptional level via NF-kappaB, HNF-1alpha, and CDX2. Occludin was hyperphosphorylated by IL-1beta treatment and was inhibited by treatment with a PI3-kinase inhibitor. These results demonstrate that MAP-kinase, p38 MAP-kinase, and PI3-kinase are distinctly involved in the regulation of hepatic gap and tight junctions during the acute-phase response to IL-1beta.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • CDX2 Transcription Factor
  • Claudins
  • Connexins / antagonists & inhibitors
  • Connexins / metabolism*
  • DNA-Binding Proteins / metabolism
  • Enzyme Inhibitors / pharmacology
  • Gap Junction beta-1 Protein
  • Gap Junctions / drug effects
  • Gap Junctions / metabolism
  • Gene Expression Regulation
  • Hepatocyte Nuclear Factor 1
  • Hepatocyte Nuclear Factor 1-alpha
  • Hepatocytes / drug effects
  • Hepatocytes / metabolism*
  • Homeodomain Proteins / metabolism
  • Interleukin-1 / pharmacology*
  • Male
  • Membrane Proteins / metabolism*
  • Mice
  • Mitogen-Activated Protein Kinases / antagonists & inhibitors*
  • Mitogen-Activated Protein Kinases / metabolism
  • NF-kappa B / metabolism
  • Nuclear Proteins / metabolism
  • Occludin
  • Phosphatidylinositol 3-Kinases / metabolism
  • Phosphorylation
  • Rats
  • Rats, Inbred F344
  • Rats, Sprague-Dawley
  • Signal Transduction*
  • Thioacetamide / pharmacology
  • Tight Junctions / drug effects
  • Tight Junctions / metabolism
  • Transcription Factors / metabolism

Substances

  • CDX2 Transcription Factor
  • Cdx2 protein, mouse
  • Claudins
  • Cldn2 protein, mouse
  • Cldn2 protein, rat
  • Connexins
  • DNA-Binding Proteins
  • Enzyme Inhibitors
  • Hepatocyte Nuclear Factor 1-alpha
  • Hnf1a protein, mouse
  • Hnf1a protein, rat
  • Homeodomain Proteins
  • Interleukin-1
  • Membrane Proteins
  • NF-kappa B
  • Nuclear Proteins
  • Occludin
  • Ocln protein, mouse
  • Ocln protein, rat
  • Transcription Factors
  • Thioacetamide
  • Hepatocyte Nuclear Factor 1
  • Phosphatidylinositol 3-Kinases
  • Mitogen-Activated Protein Kinases